CFO of Relmada Therapeutics, Inc. (NASDAQ:RLMD), Shenouda Maged, sells 3,603 shares worth $126,242
According to Relmada Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:25 PM, company CFO, Shenouda Maged disclosed selling 3,603 shares at a cost of $35.04. At the time of this transaction (Feb 08), this trade was worth $126,242 in total. As of Feb 08, Shenouda Maged now owns 9,997 shares in total worth about $349,395.15.
For the last few recent trades made by Relmada Therapeutics, Inc. (NASDAQ:RLMD) CFO, Shenouda Maged, we have the following information:
- SEC Form 4 filing: Feb 09: Sold 5,359 shares at the rate of $35.24 per share. Total worth of this trade was $188,843. Total number of shares owned as of Feb 09 were 4,638
- SEC Form 4 filing: Feb 10: Sold 2,410 shares at the rate of $35.20 per share. Total worth of this trade was $84,825. Total number of shares owned as of Feb 10 were 2,228
- SEC Form 4 filing: Feb 02: Sold 3,100 shares at the rate of $35.04 per share. Total worth of this trade was $108,634. Total number of shares owned as of Feb 02 were 2,328
Posted by
George Daniels
on Wednesday February 10 2021, 10:46 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
